BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 22252394)

  • 1. Somatic mutations affecting the selectivity filter of KCNJ5 are frequent in 2 large unselected collections of adrenal aldosteronomas.
    Azizan EA; Murthy M; Stowasser M; Gordon R; Kowalski B; Xu S; Brown MJ; O'Shaughnessy KM
    Hypertension; 2012 Mar; 59(3):587-91. PubMed ID: 22252394
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of a novel somatic KCNJ5 mutation delI157 in an aldosterone-producing adenoma.
    Murthy M; Azizan EA; Brown MJ; O'Shaughnessy KM
    J Hypertens; 2012 Sep; 30(9):1827-33. PubMed ID: 22743686
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Somatic ATP1A1, ATP2B3, and KCNJ5 mutations in aldosterone-producing adenomas.
    Williams TA; Monticone S; Schack VR; Stindl J; Burrello J; Buffolo F; Annaratone L; Castellano I; Beuschlein F; Reincke M; Lucatello B; Ronconi V; Fallo F; Bernini G; Maccario M; Giacchetti G; Veglio F; Warth R; Vilsen B; Mulatero P
    Hypertension; 2014 Jan; 63(1):188-95. PubMed ID: 24082052
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence, clinical, and molecular correlates of KCNJ5 mutations in primary aldosteronism.
    Boulkroun S; Beuschlein F; Rossi GP; Golib-Dzib JF; Fischer E; Amar L; Mulatero P; Samson-Couterie B; Hahner S; Quinkler M; Fallo F; Letizia C; Allolio B; Ceolotto G; Cicala MV; Lang K; Lefebvre H; Lenzini L; Maniero C; Monticone S; Perrocheau M; Pilon C; Plouin PF; Rayes N; Seccia TM; Veglio F; Williams TA; Zinnamosca L; Mantero F; Benecke A; Jeunemaitre X; Reincke M; Zennaro MC
    Hypertension; 2012 Mar; 59(3):592-8. PubMed ID: 22275527
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic spectrum and clinical correlates of somatic mutations in aldosterone-producing adenoma.
    Fernandes-Rosa FL; Williams TA; Riester A; Steichen O; Beuschlein F; Boulkroun S; Strom TM; Monticone S; Amar L; Meatchi T; Mantero F; Cicala MV; Quinkler M; Fallo F; Allolio B; Bernini G; Maccario M; Giacchetti G; Jeunemaitre X; Mulatero P; Reincke M; Zennaro MC
    Hypertension; 2014 Aug; 64(2):354-61. PubMed ID: 24866132
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Macrolides Blunt Aldosterone Biosynthesis: A Proof-of-Concept Study in
    Caroccia B; Prisco S; Seccia TM; Piazza M; Maiolino G; Rossi GP
    Hypertension; 2017 Dec; 70(6):1238-1242. PubMed ID: 28993452
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characteristics of Japanese aldosterone-producing adenomas with KCNJ5 mutations.
    Okamura T; Nakajima Y; Katano-Toki A; Horiguchi K; Matsumoto S; Yoshino S; Yamada E; Tomaru T; Ishii S; Saito T; Ozawa A; Shibusawa N; Satoh T; Okada S; Nagaoka R; Takada D; Horiguchi J; Oyama T; Yamada M
    Endocr J; 2017 Jan; 64(1):39-47. PubMed ID: 27681703
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New insights into aldosterone-producing adenomas and hereditary aldosteronism: mutations in the K+ channel KCNJ5.
    Scholl UI; Lifton RP
    Curr Opin Nephrol Hypertens; 2013 Mar; 22(2):141-7. PubMed ID: 23318698
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aldosterone-Producing Adenomas: Histopathology-Genotype Correlation and Identification of a Novel
    Tan GC; Negro G; Pinggera A; Tizen Laim NMS; Mohamed Rose I; Ceral J; Ryska A; Chin LK; Kamaruddin NA; Mohd Mokhtar N; A Jamal AR; Sukor N; Solar M; Striessnig J; Brown MJ; Azizan EA
    Hypertension; 2017 Jul; 70(1):129-136. PubMed ID: 28584016
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microarray, qPCR, and KCNJ5 sequencing of aldosterone-producing adenomas reveal differences in genotype and phenotype between zona glomerulosa- and zona fasciculata-like tumors.
    Azizan EA; Lam BY; Newhouse SJ; Zhou J; Kuc RE; Clarke J; Happerfield L; Marker A; Hoffman GJ; Brown MJ
    J Clin Endocrinol Metab; 2012 May; 97(5):E819-29. PubMed ID: 22442279
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel somatic mutations in primary hyperaldosteronism are related to the clinical, radiological and pathological phenotype.
    Scholl UI; Healy JM; Thiel A; Fonseca AL; Brown TC; Kunstman JW; Horne MJ; Dietrich D; Riemer J; Kücükköylü S; Reimer EN; Reis AC; Goh G; Kristiansen G; Mahajan A; Korah R; Lifton RP; Prasad ML; Carling T
    Clin Endocrinol (Oxf); 2015 Dec; 83(6):779-89. PubMed ID: 26252618
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel KCNJ5 mutations in sporadic aldosterone-producing adenoma reduce Kir3.4 membrane abundance.
    Cheng CJ; Sung CC; Wu ST; Lin YC; Sytwu HK; Huang CL; Lin SH
    J Clin Endocrinol Metab; 2015 Jan; 100(1):E155-63. PubMed ID: 25347571
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel KCNJ5-insT149 somatic mutation close to, but outside, the selectivity filter causes resistant hypertension by loss of selectivity for potassium.
    Kuppusamy M; Caroccia B; Stindl J; Bandulik S; Lenzini L; Gioco F; Fishman V; Zanotti G; Gomez-Sanchez C; Bader M; Warth R; Rossi GP
    J Clin Endocrinol Metab; 2014 Sep; 99(9):E1765-73. PubMed ID: 25057880
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NEFM (Neurofilament Medium) Polypeptide, a Marker for Zona Glomerulosa Cells in Human Adrenal, Inhibits D1R (Dopamine D1 Receptor)-Mediated Secretion of Aldosterone.
    Maniero C; Garg S; Zhao W; Johnson TI; Zhou J; Gurnell M; Brown MJ
    Hypertension; 2017 Aug; 70(2):357-364. PubMed ID: 28584012
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Somatic mutations in the KCNJ5 gene raise the lateralization index: implications for the diagnosis of primary aldosteronism by adrenal vein sampling.
    Seccia TM; Mantero F; Letizia C; Kuppusamy M; Caroccia B; Barisa M; Cicala MV; Miotto D; Rossi GP
    J Clin Endocrinol Metab; 2012 Dec; 97(12):E2307-13. PubMed ID: 23012392
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical and Steroidogenic Characteristics of Aldosterone-Producing Adenomas With ATPase or CACNA1D Gene Mutations.
    Kitamoto T; Suematsu S; Yamazaki Y; Nakamura Y; Sasano H; Matsuzawa Y; Saito J; Omura M; Nishikawa T
    J Clin Endocrinol Metab; 2016 Feb; 101(2):494-503. PubMed ID: 26606680
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression and mutations of KCNJ5 mRNA in Japanese patients with aldosterone-producing adenomas.
    Taguchi R; Yamada M; Nakajima Y; Satoh T; Hashimoto K; Shibusawa N; Ozawa A; Okada S; Rokutanda N; Takata D; Koibuchi Y; Horiguchi J; Oyama T; Takeyoshi I; Mori M
    J Clin Endocrinol Metab; 2012 Apr; 97(4):1311-9. PubMed ID: 22278422
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lack of influence of somatic mutations on steroid gradients during adrenal vein sampling in aldosterone-producing adenoma patients.
    Oßwald A; Fischer E; Degenhart C; Quinkler M; Bidlingmaier M; Pallauf A; Lang K; Mussack T; Hallfeldt K; Beuschlein F; Reincke M
    Eur J Endocrinol; 2013 Nov; 169(5):657-63. PubMed ID: 23946277
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutations in KCNJ5 determines presentation and likelihood of cure in primary hyperaldosteronism.
    Ip JC; Pang TC; Pon CK; Zhao JT; Sywak MS; Gill AJ; Soon PS; Sidhu SB
    ANZ J Surg; 2015 Apr; 85(4):279-83. PubMed ID: 24274318
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of cardiovascular complications in patients with and without KCNJ5 gene mutations harboring aldosterone-producing adenomas.
    Kitamoto T; Suematsu S; Matsuzawa Y; Saito J; Omura M; Nishikawa T
    J Atheroscler Thromb; 2015; 22(2):191-200. PubMed ID: 25253161
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.